These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 21167610

  • 1. Biological responses towards cationic peptides and drug carriers.
    Verdurmen WP, Brock R.
    Trends Pharmacol Sci; 2011 Feb; 32(2):116-24. PubMed ID: 21167610
    [Abstract] [Full Text] [Related]

  • 2. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
    Wang F, Wang Y, Zhang X, Zhang W, Guo S, Jin F.
    J Control Release; 2014 Jan 28; 174():126-36. PubMed ID: 24291335
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
    Verdurmen WP, Thanos M, Ruttekolk IR, Gulbins E, Brock R.
    J Control Release; 2010 Oct 15; 147(2):171-9. PubMed ID: 20620184
    [Abstract] [Full Text] [Related]

  • 5. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P, Mäger I, Langel Ü.
    Trends Pharmacol Sci; 2010 Nov 15; 31(11):528-35. PubMed ID: 20828841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Classes and prediction of cell-penetrating peptides.
    Lindgren M, Langel U.
    Methods Mol Biol; 2011 Nov 15; 683():3-19. PubMed ID: 21053118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
    Mäe M, Andaloussi SE, Lehto T, Langel U.
    Expert Opin Drug Deliv; 2009 Nov 15; 6(11):1195-205. PubMed ID: 19831582
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB, Pereira MP, Kelley SO.
    Adv Drug Deliv Rev; 2009 Sep 30; 61(11):953-64. PubMed ID: 19538995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A, Vaidya B, Khatri K, Goyal AK, Gupta PN, Mahor S, Paliwal R, Rai S, Vyas SP.
    Pharmazie; 2007 Sep 30; 62(9):643-58. PubMed ID: 17944316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C, Nielsen HM.
    Expert Opin Drug Deliv; 2008 Jan 30; 5(1):105-17. PubMed ID: 18095931
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M, Langel U.
    Methods Mol Biol; 2005 Jan 30; 298():77-89. PubMed ID: 16044541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The pharmacokinetics of cell-penetrating peptides.
    Sarko D, Beijer B, Garcia Boy R, Nothelfer EM, Leotta K, Eisenhut M, Altmann A, Haberkorn U, Mier W.
    Mol Pharm; 2010 Dec 06; 7(6):2224-31. PubMed ID: 20845937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.